Transcriptional activation of human GM3 synthase (hST3Gal V) gene by valproic acid in ARPE-19 human retinal pigment epithelial cells
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
The present study demonstrated that valproic acid (VPA) transcriptionally regulates human GM3 synthase (hST3Gal V),which catalyzes ganglioside GM3 biosynthesis in ARPE-19 human retinal pigment epithelial cells. For this, we characterized the promoter region of the hST3Gal V gene. Functional analysis of the 5’-flanking region of the hST3Gal V gene revealed that the -177 to -83 region functions as the VPA-inducible promoter and that the CREB/ATF binding site at -143 is crucial for VPA-induced expression of hST3Gal V in ARPE-19 cells. In addition,the transcriptional activity of hST3Gal V induced by VPA in ARPE-19 cells was inhibited by SP600125, a c-Jun N-terminal kinase (JNK) inhibitor. In summary, our results identified the core promoter region in the hST3Gal V promoter and for the first time demonstrated that ATF2 binding to the CREB/ATF binding site at -143 is essential for transcriptional activation of hST3Gal V in VPA-induced ARPE-19 cells. [BMB reports 2011; 44(6): 405-409]
Abstract
The present study demonstrated that valproic acid (VPA) transcriptionally regulates human GM3 synthase (hST3Gal V),which catalyzes ganglioside GM3 biosynthesis in ARPE-19 human retinal pigment epithelial cells. For this, we characterized the promoter region of the hST3Gal V gene. Functional analysis of the 5’-flanking region of the hST3Gal V gene revealed that the -177 to -83 region functions as the VPA-inducible promoter and that the CREB/ATF binding site at -143 is crucial for VPA-induced expression of hST3Gal V in ARPE-19 cells. In addition,the transcriptional activity of hST3Gal V induced by VPA in ARPE-19 cells was inhibited by SP600125, a c-Jun N-terminal kinase (JNK) inhibitor. In summary, our results identified the core promoter region in the hST3Gal V promoter and for the first time demonstrated that ATF2 binding to the CREB/ATF binding site at -143 is essential for transcriptional activation of hST3Gal V in VPA-induced ARPE-19 cells. [BMB reports 2011; 44(6): 405-409]
참고문헌 (15)
- Rogawski, M. A, "The neurobiology of antiepileptic drugs", Nat. Rev. Neurosci, 5, pp.553~564 (2004)
- Blaheta, R. A, "Evolving anticancer drug valproic acid: insights into the mechanism and clinical studies", Med. Res. Rev, 25, pp.383~397 (2005)
- Blaheta, R. A, "Anti-tumor mechanisms of valproate: a novel role for an old drug", Med. Res. Rev, 22, pp.492~511 (2002)
- Hakomori, S, "Structure, organization, and function of glycosphingolipids in membrane", Curr. Opin. Hematol, 10, pp.16~24 (2003)
- Bektas, M, "Glycosphingolipids and cell death", Glycoconjugate J, 20, pp.39~47 (2004)
- Kwon, H. Y., "Valproic acid-mediated transcriptional regulation of human GM3 synthase (hST3Gal V) in SK-N-BE(2)-C human neuroblastoma cells", Acta. Pharmacol. Sin, 29, pp.999~1005 (2008)
- Haw-Young Kwon, "Valproic Acid Induces Transcriptional Activation of Human GD3 Synthase (hST8Sia I) in SK-N-BE(2)-C Human Neuroblastoma Cells", Molecules and Cells, 27(1), pp.113~118 (2009), 한국분자세포생물학회
- Cinatl Jr., J, "Antitumor activity of sodium valproate in cultures of human neuroblastoma cells", Anticancer Drugs, 7, pp.766~773 (1996)
- Cinatl Jr., J, "Sodium valproate inhibits in vivo growth of human neuroblastoma cells", Anticancer Drugs, 8, pp.958~963 (1997)
- Choi, H. J, "Transcriptional regulation of the human GM3 synthase (hST3Gal V) gene during monocytic differentiation of HL-60 cells", FEBS Lett, 555, pp.204~208 (2003)
- Chung, T. W, "Molecular mechanism for transcriptional activation of ganglioside GM3 synthase and its function in differentiation of HL-60 cells", Glycobiology, 15, pp.233~244 (2005)
- Kim, S. W, "Isolation and characterization of the promoter region of the human GM3 synthase gene", Biochim. Biophys. Acta, 1578, pp.84~89 (2002)
- Gupta, S, "Transcription factor ATF2 regulation by the JNK signal transduction pathway", Science, 267, pp.389~393 (1995)
- Bhoumik, A, "ATF2: a transcription factor that elicits oncogenic or tumor suppressor activities", Cell Cycle, 7, pp.2341~2345 (2008)
- Morton, S, "Signaling pathways involved in multisite phosphorylation of the transcription factor ATF-2", FEBS Lett, 572, pp.177~183 (2004)